Palvella Therapeutics, Inc.
PVLA
$156.13
-$0.42-0.27%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -130.92% | -92.63% | -221.79% | -67.45% | -127.01% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 151.36% | 124.75% | 88.73% | 72.46% | 85.27% |
| Change in Net Operating Assets | 52.21% | 52.95% | 207.06% | -107.91% | 13.09% |
| Cash from Operations | -136.38% | -60.52% | 8.66% | -187.31% | -238.99% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 266.76% | 344,610.45% | -99.83% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -1,178.57% | -101.75% | 100.00% | 100.00% |
| Cash from Financing | 266.76% | 17,964.48% | -100.07% | -89.97% | -96.47% |
| Foreign Exchange rate Adjustments | 105.56% | -150.00% | -20,433.33% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -258.00% | 1,960.73% | -108.05% | -1,980.61% | -162.65% |